Dimension Capital
Venture capitalActively deployingSan Francisco · Seed–Late Stage · 13 people tracked
Also known as DIMENSION CAPITAL MANAGEMENT LLC · DIMENSION MANAGEMENT, L.P.
Investment thesis
Dimension positions itself as a multistage, research-oriented investment firm focused on companies operating at the frontiers of science and computing. It emphasizes a research-driven approach, backing ventures that combine advances in the life sciences and computational fields.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 14 of 28 portfolio companiesAI & Machine Learning ×11Biotech ×11Deep Tech ×5Healthtech ×4SaaS ×3Developer Tools ×2Enterprise Software ×2Cloud Computing ×1
HQs:United States×14Germany×1
Investments · 28 tracked
founders shown can be your intro pathBiotechHayward, US
Roger M. Perlmutter(Executive Officer, Director)Adam Goulburn(Director)
BoardJoshua Wolfe(Director)Dror Berman(Director)James Tananbaum(Director)Leon Chen(Director)
Board seatAdam Goulburn· per SEC Form D · $525M raise · filed Jan 2022
Boston, US
Board seatNan Li· per SEC Form D · $214M raise · filed Dec 2025
Monte Rosa Therapeutics is a biopharmaceutical company developing molecular glue degrader (MGD) therapeutics using its QuEEN discovery engine, targeting oncology, neuroscience, and immune-mediated diseases.
AI & Machine LearningBiotechHealthtechBoston, US
Alexander Mayweg(Director)Bradley Bolzon(Director)Markus Warmuth(M.D., Chief Executive Officer)Ali Behbahani(Director)Kim Blackwell(Director)Sharon Townson(Ph.D., Chief Scientific Officer)
San Francisco, US
Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)Joshua Wolfe(Director)Matt Ocko(Director)Adam Goulburn(Director)
Board seatAdam Goulburn· per SEC Form D · $14M raise · filed Jul 2016
New York, US
Adam Goulburn(Director)Nathan Jenkins(Executive Officer)David Teten(Director)Alberto Pepe(Executive Officer, Director)Matteo Cantiello(Director)
Board seatAdam Goulburn· per SEC Form D · $1.5M raise · filed Jan 2016
New York, US
Joshua Bruno(Executive Officer, Director)Adam Goulburn(Director)Brad Gillespie(Director)Ann Lamont(Director)
Board seatAdam Goulburn· per SEC Form D · $30.3M raise · filed Jan 2016
New York, US
Nicholas Horbaczewski(Executive Officer, Director)
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2019
Boulder, US
Board seatZavain Dar· per SEC Form D · $62.5M raise · filed Mar 2023
New York, US
Board seatAdam Goulburn· per SEC Form D · $15.1M raise · filed Jun 2022
NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.
AI & Machine LearningBiotechLongevity
Brian Armstrong(Co-founder, Board of Directors)Blake Byers(Director)Jacob Kimmel(Director)Michael Polansky(Executive Officer)
Board seatZavain Dar· per SEC Form D
Pager Health provides AI-powered care navigation and virtual health services for health plans, combining clinician expertise with machine learning to help members find appropriate care and improve health outcomes.
AI & Machine LearningDigital HealthHealthtechNew York, US
Gaspard de Dreuzy(Executive Officer, Director)Lisa Skate Tatum(Director)Phillip Eytan(Executive Officer, Director)Oscar Salazar(Director)Darren Dworkin(Director)Adam Goulburn(Director)
Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2021
San Francisco, US
Board seatZavain Dar· per SEC Form D · $20.7M raise · filed Aug 2017
Biotech company focused on discovery of novel medicines.
BiotechNew York, US
Julie Sunderland(Director)Josh Wolfe(Director)Kaja Wasik(Executive Officer, Director)Andrew Farnum(Executive Officer, Director)
BoardBob More(Director)
Board seatAdam Goulburn· per SEC Form D · $31.5M raise · filed Oct 2019
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design.
AI & Machine LearningBiotechDeep Tech
John Chodera(President / CEO)Theofanis Karaletsos
BoardZavain Dar(Board)
Aspect Bio Systems develops bioprinted tissue therapeutics for regenerative medicine using a platform that combines AI-powered bioprinting, computational design, therapeutic cells, and biomaterials.
AI & Machine LearningBiotechDeep Tech
Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
AI & Machine LearningDeep TechHardwareHealthtechLegalTechRoboticsSaaS
Mostafa ElSayed(CEO and Co-Founder)Suryansh Chandra(Co-Founder)
Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.
AI & Machine LearningBiotechDeep Tech
Kaleidoscope provides a software platform for scientific R&D teams to track and communicate project data, manage complex research processes, and accelerate decision-making.
BiotechEnterprise SoftwareSaaS
Ewan Taylor(CSO and Co-founder)Geraldine Paulus(Co-founder, VP Operations)Brian Naughton(Co-founder and CTO)in
Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma.
AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsHealthtechMunich, DE
Alex Wolf(Co-Founder & CEO)inSunny Sun(Founder)inFrederic Enard(Co-CTO & Founding Engineer)
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Public market activity · per SEC filings
what is this? ⓘ2 insider ownership filings (Forms 3/4/5)
at Odyssey Therapeutics, Inc. (ODTX)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- What stage does Dimension Capital invest at?
- Dimension Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Dimension Capital's typical check size?
- Dimension Capital typically writes checks of $1M – $10M.
- What sectors does Dimension Capital focus on?
- Dimension Capital focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, Medical Devices, SaaS.
- Where is Dimension Capital located?
- Dimension Capital is headquartered in San Francisco, US.
- Does Dimension Capital lead rounds?
- Yes, Dimension Capital leads investment rounds.
Media · Podcasts & interviews
featuring the teamVentures #18 w/ Zavain Dar & Nan Li - Co-Founders & Managing Partners @ Dimension Capital | BIOS
BIOS · Nan Li
Images
Co-investors · 48
Amplify Partners is an early-stage venture firm that has invested in technical founders — engineers, researchers, and scientists — building applications, AI models, developer tools, and infrastructure since 2012.
General Catalyst is a venture capital and investment firm that backs founders across industries, with a strong focus on AI-driven transformation, fintech, healthcare, and other sectors.
Lux Capital's portfolio page showcasing select companies across science and technology sectors including AI infrastructure, aerospace, biotech, and productivity software.
Menlo Ventures is a venture capital firm that backs transformative, early-stage technology companies reshaping how people live and work.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
True Ventures is an early-stage venture capital firm that writes the first check for founders and supports them through subsequent stages of growth.
Streamlined Ventures is an early-stage venture firm that partners with founders and invests at the seed stage to help build large-scale companies.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
The Column Group (TCG) is a venture capital firm focused on building and backing biotechnology companies, applying an edge-to-edge investment model centered on company formation with capacity for long-term private and public capital support.
▶36 more co-investors
CompoundFPVKinnevikAndreessen HorowitzUncork CapitalFelicis VenturesFoundation CapitalSpark CapitalUnion Square Ventures (USV)Susa VenturesInnovation EndeavorsStellar CapitalAdditionTrajectory VenturesMaveron01 Advisors2048 VenturesFootworkBrainchild HoldingsPelion Venture PartnersDigital Currency GroupPoint72 VenturesOyster VenturesHOF CapitalCrunchFundLombardstreet VenturesEuclid Venture PartnersBuilders VCPivotal bioVenture PartnersAnkona Capital Partners6 Dimensions CapitalBerkeley Blockchain XceleratorCatalio Capital ManagementAmplitude Venture CapitalInterlagosAvant Bio
Firms observed investing alongside Dimension Capital, from public investor directories. Shared companies are the overlap with Dimension Capital's recorded portfolio.
Similar investors
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Norwest is a venture and growth equity investment firm that has backed over 700 companies across sectors including AI, retail, and healthcare, working alongside entrepreneurs from early to late-stage growth.